Minerva Neurosciences launches $75M at-the-market offering; shares last closed at $5.22

Filed May 27, 2026 · ~1 min read

Key Changes

• high

  Minerva may sell up to $75M of common stock from time to time under an at-the-market Sales Agreement, with no minimum price or committed amount.

  Use of Proceeds verify on EDGAR →
• high

  New investors face immediate dilution of $8.60 per share based on an assumed offering price of $6.30, rising to $9.73 if shares are sold at $7.30.

  Dilution verify on EDGAR →
• medium

  Net proceeds are earmarked for general corporate purposes, including clinical trials, R&D, working capital, and potential acquisitions, with broad management discretion.

  Use of Proceeds verify on EDGAR →